- Home
- TIC vs DYN Comparison
TIC vs DYN Comparison
Compare TIC & DYN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TIC
- DYN
- Stock Information
- Founded
- TIC 1991
- DYN 1984
- Country
- TIC United States
- DYN United States
- Employees
- TIC N/A
- DYN N/A
- Industry
- TIC
- DYN Medicinal Chemicals and Botanical Products
- Sector
- TIC
- DYN Health Care
- Exchange
- TIC Nasdaq
- DYN Nasdaq
- Market Cap
- TIC 1.3B
- DYN 1.4B
- IPO Year
- TIC N/A
- DYN 2020
- Fundamental
- Price
- TIC $10.52
- DYN $12.58
- Analyst Decision
- TIC Hold
- DYN Strong Buy
- Analyst Count
- TIC 1
- DYN 15
- Target Price
- TIC $11.00
- DYN $36.00
- AVG Volume (30 Days)
- TIC 3.2M
- DYN 2.9M
- Earning Date
- TIC 08-14-2025
- DYN 07-28-2025
- Dividend Yield
- TIC N/A
- DYN N/A
- EPS Growth
- TIC N/A
- DYN N/A
- EPS
- TIC N/A
- DYN N/A
- Revenue
- TIC $1,113,179,000.00
- DYN N/A
- Revenue This Year
- TIC $5.80
- DYN N/A
- Revenue Next Year
- TIC $5.77
- DYN N/A
- P/E Ratio
- TIC N/A
- DYN N/A
- Revenue Growth
- TIC 4.23
- DYN N/A
- 52 Week Low
- TIC $8.76
- DYN $6.36
- 52 Week High
- TIC $14.28
- DYN $47.06
- Technical
- Relative Strength Index (RSI)
- TIC N/A
- DYN 67.54
- Support Level
- TIC N/A
- DYN $11.65
- Resistance Level
- TIC N/A
- DYN $12.68
- Average True Range (ATR)
- TIC 0.00
- DYN 0.78
- MACD
- TIC 0.00
- DYN 0.11
- Stochastic Oscillator
- TIC 0.00
- DYN 74.52
About TIC Acuren Corporation Common Stock
Acuren Corp operates as a provider of critical asset integrity services. The company provides testing, inspection, engineering and lab testing services in different industrial markets such as chemical, pipeline, refinery, power generation, oilsands, automotive, aerospace, mining, manufacturing, renewable energy, and pulp and paper. The company's service line includes Nondestructive Testing (NDT) techniques such as radiography, ultrasonic testing, magnetic particle inspection, penetrant testing, etc., Rope Access Technician Solutions (RAT), and Engineering and Lab Testing. The company has two operating and reportable segments, which are the United States, generating maximum revenue, and Canada.
About DYN Dyne Therapeutics Inc.
Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases. Its FORCE platform develops targeted therapeutics that are designed to overcome limitations in delivery to muscle tissue and the central nervous system, or CNS. Its FORCE platform therapeutics consist of a payload that is rationally designed to target the genetic basis of the disease are seeking to treat, a linker, and an antigen-binding fragment, that attaches to the payload using the linker. Its Pipeline includes DYNE-101, DYNE-251, DYNE-302, and DYNE-401.